ZYNERBA PHARMACEUTICALS, INC. Accrued Liabilities, Current
ZYNERBA PHARMACEUTICALS, INC. had Accrued Liabilities, Current of $8.76 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2023-08-14
- 2023-06-30: Accrued Liabilities, Current $8.76M.
- 2023-03-31: Accrued Liabilities, Current $7.25M.
- 2022-12-31: Accrued Liabilities, Current $7.01M.
- 2022-09-30: Accrued Liabilities, Current $7.60M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2023-06-30 | $8.76M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $7.25M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $7.01M 10-Q · filed 2023-08-14 |
| 2022-09-30 | $7.60M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $7.64M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $7.10M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $7.90M 10-K · filed 2023-03-28 |
| 2021-09-30 | $8.05M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $8.00M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $10.68M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $11.28M 10-K · filed 2022-03-01 |
| 2020-09-30 | $6.99M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $8.94M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $6.68M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $7.07M 10-K · filed 2021-03-10 |
| 2019-09-30 | $5.84M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $6.03M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $3.27M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $5.26M 10-K · filed 2020-03-10 |
| 2018-09-30 | $5.42M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $4.91M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $4.13M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $3.92M 10-K · filed 2019-03-11 |
| 2017-09-30 | $4.48M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $5.00M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $5.11M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $4.28M 10-K · filed 2018-03-12 |
| 2016-09-30 | $2.88M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $1.52M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $1.09M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $2.27M 10-K · filed 2017-03-27 |
| 2015-09-30 | $1.21M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $1.26M 10-Q · filed 2015-08-27 |
| 2014-12-31 | $1.71M 10-K · filed 2016-03-14 |